|
 |
- A Phase I/II Study of Temsirolimus (CCI-779) in Children with Relapsed or Refractory Solid Tumors (Part 2)
Dunkel, Ira, MD
[Protocol 07-060]
- A Phase II Study of Pemetrexed in Children with Recurrent Malignancies
Trippett, Tanya, MD
[Protocol 07-179]
- A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma
Wexler, Leonard, MD
[Protocol 03-099]
- A Phase II Trial of R1507 for People with Recurrent Sarcoma
Maki, Robert, MD
[Protocol 07-166]
- Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide in Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid Rhabdomyosarcoma
Wexler, Leonard, MD
[Protocol 05-032]
Last Updated: Jan. 25, 2006
|
|
|
|
|
